Likewise, GFPT1 stabilizes PD-L1 via O-GlcNAcylation, which promotes IFNγ-induced PD-L1 activation and reduces T-cell and NK-cell efficacy against lung cancer cells [167]. The gene discussed is GFPT1; the disease is lung cancer.